Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC von Hooijman, Eline L., Chalashkan, Yozlem, Ling, Sui Wai, Kahyargil, Figen F., Segbers, Marcel, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn L. W., Brabander, Tessa, de Blois, Erik

Volltext

Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives von Hooijman, Eline L., Radchenko, Valery, Ling, Sui Wai, Konijnenberg, Mark, Brabander, Tessa, Koolen, Stijn L. W., de Blois, Erik

Volltext

Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer von Ling, Sui Wai, de Blois, Erik, Hooijman, Eline, van der Veldt, Astrid, Brabander, Tessa

Volltext

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PS... von Hooijman, Eline L., Ntihabose, Carolline M., Reuvers, Thom G. A., Nonnekens, Julie, Aalbersberg, Else A., van de Merbel, Jordy R. J. P., Huijmans, Judith E., Koolen, Stijn L. W., Hendrikx, Jeroen J. M. A., de Blois, Erik

Volltext

Advances in [sup.177]Lu-PSMA and [sup.225]Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer von Ling, Sui Wai, de Blois, Erik, Hooijman, Eline, van der Veldt, Astrid, Brabander, Tessa

Volltext

Evaluation of the tolerability and safety of 225AcAc-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study von Ling, Sui Wai, van der Veldt, Astrid A M, Konijnenberg, Mark, Segbers, Marcel, Hooijman, Eline, Bruchertseifer, Frank, Morgenstern, Alfred, de Blois, Erik, Brabander, Tessa

Volltext

Evaluation of the tolerability and safety of [ 225 Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study von Ling, Sui Wai, van der Veldt, Astrid A M, Konijnenberg, Mark, Segbers, Marcel, Hooijman, Eline, Bruchertseifer, Frank, Morgenstern, Alfred, de Blois, Erik, Brabander, Tessa

Volltext

SSP-14 - Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC von Hooijman, Eline, Chalashkan, Yozlem, Ling, Sui, Kahyargil, Figen, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn, Brabander, Tessa, de Blois, Erik

Volltext

Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC von Hooijman, Eline, Chalashkan, Yozlem, Ling, Sui, Kahyargil, Figen, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn, Brabander, Tessa, de Blois, Erik

Volltext

Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I T in patients with metastatic prostate cancer: a phase I dose escalation study von Sui wai Ling, Astrid A. M. van der Veldt, Mark Konijnenberg, Marcel Segbers, Eline Hooijman, Frank Bruchertseifer, Alfred Morgenstern, Erik de Blois, Tessa Brabander

Volltext

A qualitative analysis of student experiences of a blended learning course von Ruijten, Peter, Hooijman, Eline

Volltext bestellen

Development of [225Ac]Ac-PSMA-I T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC von Eline L. Hooijman, Yozlem Chalashkan, Sui Wai Ling, Figen F. Kahyargil, Marcel Segbers, Frank Bruchertseifer, Alfred Morgenstern, Yann Seimbille, Stijn L. W. Koolen, Tessa Brabander, Erik de Blois

Volltext